Lab Services

Forecast Recompete Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Incumbent contract
Anticipated award
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Indian Health Service is recompeting procurement of in-vitro diagnostic services, specifically blood unit retypes and immunohematological testing services, with an estimated solicitation release on January 1, 2027 and estimated award on April 1, 2027. The contract covers diagnostic testing services to support IHS healthcare delivery, classified under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), with no set-aside designation indicating full and open competition.

The estimated award value ranges from $25,000 to $250,000. Performance takes place at the BFSU Laboratory in Browning, Montana. Points of contact are Andrew Baughn (andrew.baughn@ihs.gov) and Contracting Officer DeeAndra Salabye (deeandra.salabye@ihs.gov; 406-208-8857).

The recompeted award is Purchase Order 75H70926P00055, a firm fixed-price purchase order awarded to Northern Plains Laboratory LLC on April 1, 2026 for $34,960 with performance through March 31, 2027. This purchase order was issued under Northern Plains Laboratory's parent Indefinite Delivery/Indefinite Quantity contract (Number 75H70623D00014), valued at approximately $15.3 million through March 4, 2027, which enables the IHS to procure comprehensive reference laboratory testing and pathology services across twelve IHS healthcare facilities in the Great Plains states.

Forecast text

NPL_Immuno-Hematological Testing Services

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast